AltruBio

Drug Discovery · San Francisco, CA · Founded 2000 · Privately Held (backing)

Developer of first-in-class immune-modulators to target diseases of the immune system. AltruBio is based in San Francisco, CA and was founded in 2000. It has raised $337 million across 1 recorded round; the latest was a $225 million Series B in May 2024.

Last price · $/share
—
Implied valuation
—
Total raised
$336.6M
Last round
Later Stage VC (Series B)
May 2024
Cap table — not yet on record

AltruBio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AltruBio with a free account
  • ·Watch AltruBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about AltruBio

Where does AltruBio's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across AltruBio's 1 recorded funding rounds.